Medicrea Highlights UNiD™ ASI Technology at State of Spine Surgery Think Tank 2017

LYON, France & NEW YORK–(BUSINESS WIRE)– The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED),
pioneering the convergence of healthcare IT and next-generation,
outcome-centered device design and manufacturing with UNiD™ ASI
technology, announced today that the Company participated in the recent
State of Spine Surgery Think Tank in Los Cabos, Mexico, from June 15 to
June 17, 2017, where it highlighted its UNiD™ ASI technology for
Adaptive Spine Intelligence™.

On Friday, June 16, 2017, the Company’s data-driven, system-based
approach to personalized spine surgery was featured in a panel
discussion entitled “Adaptive Spine Intelligence and its Influence on
Spinal Treatment Options” supported by Medicrea’s Chief Commercial
Officer and Business Development Officer, Rick Kienzle, Chief Scientific
Officer, Thomas Mosnier PhD, as well as orthopedic surgeon and UC Denver
faculty member, Dr Christopher J. Kleck, MD. The panel was moderated by
Co-Chairman of the event, Dr Alex Vaccaro, MD, PhD.

Rick Kienzle stated, “The 14th Annual Cabo Meeting provided a great
opportunity for us to engage candidly with surgeon thought-leaders in an
intimate setting that is focused on pointing to the future of spinal
care. Our UNiD™ ASI technology was perfectly suited to this environment
as it centers on creating an adaptive and intelligent collaboration
between surgeons and industry.” Mr Kienzle continued, “We are the only
Spine company integrating machine learning technology with
next-generation Surgeon and patient-specific design / manufacturing
techniques. We were pleased to share how we use proprietary data science
to drive outcome, especially with the recent FDA
clearance of our UNiD™ HUB software.”

“Data analytics and predictive modeling are topics that surgeons and
healthcare professionals recognize will shape the future of care and the
way we view spine surgery,” Thomas Mosnier stated. “In our panel
discussion, we explored how UNiD™ ASI technology fills a void created by
traditional manufacturers who only address implant design. Surgeons are
excited to move in this direction so they are galvanized with the tools
they need to offer scientifically informed treatment for each patient.”

Surgeons attending the meeting were able to learn more about Medicrea
and the Company’s iterative model that has been used today to generate
strategic case planning, surgeon & patient-specific implants powering
detailed post-operative analysis in more than 1,400 UNiD™ ASI surgeries
to date.

About Medicrea (www.Medicrea.com)

Through the lens of predictive medicine, Medicrea leads the design,
integrated manufacture, and distribution of 30+ FDA approved implant
technologies, utilized in over 100k spinal surgeries to date. Operating
in a $10 billion marketplace, Medicrea is an SME with 175 employees
worldwide, which includes 55 at its USA Corp. subsidiary in NYC. The
Company has an ultra-modern manufacturing facility in Lyon, France,
housing the development and production of 3D-printed titanium
patient-specific implants.

By leveraging its proprietary software analysis tools with big data and
machine learning technologies supported by an expansive collection of
clinical and scientific data, Medicrea is well-placed to streamline the
efficiency of spinal care, reducing procedural complications and
limiting time spent in the O.R.

For further information, please visit: Medicrea.com.

Connect with Medicrea:

FACEBOOK
| INSTAGRAM
| TWITTER
| WEBSITE
| YOUTUBE

Medicrea is listed on
EURONEXT Growth Paris
ISIN:
FR 0004178572
Ticker: ALMED

View source version on businesswire.com: http://www.businesswire.com/news/home/20170621006397/en/